NCT00140530View on ClinicalTrials.gov

Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)

PHASE4CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

June 30, 2005

Conditions
Coronary Disease
Interventions
DEVICE

Paclitaxel-eluting stent (Taxus)

patients has been implanted the Paclitaxel-eluting stent.

DEVICE

Rapamycin-eluting stent

patients has been implanted the Rapamycin-eluting stent.

Trial Locations (2)

80636

Deutsches Herzzentrum Muenchen, Munich

81675

First Medizinische Klinik, Klinikum rechts der Isar, Munich

All Listed Sponsors
collaborator

Bayerische Forschungsstiftung Muenchen

UNKNOWN

lead

Deutsches Herzzentrum Muenchen

OTHER

NCT00140530 - Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1) | Biotech Hunter | Biotech Hunter